F. Ambrogi, E. Biganzoli, and P. Boracchi. Statistics in medicine, 27 (30):
6407-25(December 2008)4677<m:linebreak></m:linebreak>JID: 8215016; ppublish;<m:linebreak></m:linebreak>Anàlisi de supervivència; Competing risks.
S. Snapinn, M. Chen, Q. Jiang, and T. Koutsoukos. Pharmaceutical statistics, 5 (4):
273-81(2006)7401<m:linebreak></m:linebreak>LR: 20071115; JID: 101201192; ppublish;<m:linebreak></m:linebreak>Mesures de contrast; RCT.
B. Djulbegovic. The Journal of medicine and philosophy, 32 (2):
79-98(2007)7494<m:linebreak></m:linebreak>LR: 20071115; GR: 1 R01 NS044417-01/NS/NINDS NIH HHS/United States; JID: 7610512; ppublish;<m:linebreak></m:linebreak>Intervenció/placebo; Recerca clínica; Ètica;.
F. Lobo, S. Wagner, C. Gross, and J. Schommer. Research in social & administrative pharmacy : RSAP, 2 (1):
143-51(March 2006)6524<m:linebreak></m:linebreak>LR: 20071115; JID: 101231974; ppublish;<m:linebreak></m:linebreak>Propensity score; Introductori.
D. Brotman, E. Walker, M. Lauer, and R. O'Brien. Archives of internal medicine, 165 (2):
138-45(January 2005)3841<m:linebreak></m:linebreak>Mesures d'associació.
G. Stewart, D. Altman, L. Askie, L. Duley, M. Simmonds, and L. Stewart. PloS one, 7 (10):
e46042(January 2012)7049<m:linebreak></m:linebreak>JID: 101285081; OID: NLM: PMC3463584; 2012/06/06 received; 2012/08/28 accepted; 2012/10/03 epublish; ppublish;.
J. Delaney, S. Daskalopoulou, and S. Suissa. Pharmacoepidemiology and drug safety, 18 (1):
1-6(January 2009)5076<m:linebreak></m:linebreak>JID: 9208369; 0 (Adrenergic beta-Antagonists); ppublish;<m:linebreak></m:linebreak>Anàlisi de dades; Marginal structural models; Exemple.
H. Bucher, G. Guyatt, L. Griffith, and S. Walter. Journal of clinical epidemiology, 50 (6):
683-91(June 1997)2443<m:linebreak></m:linebreak>Metaanàlisi.